Create a narrative

Compugen Community

NasdaqCM:CGEN Community

1 Narratives written by author
0 Comments on narratives written by author
9 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

Partnerships With AstraZeneca And Gilead Will Open New Market Opportunities

Key Takeaways Strategic collaborations with major pharmaceutical companies could significantly boost Compugen’s future revenue through milestone payments and potential royalties. Developing innovative treatments like COM701 and COM902 could open lucrative market opportunities and enhance revenue if they prove clinically successful.

US$4.00

FV

62.0% undervalued

19.36%

Revenue growth p.a.

1

0

8

1 day ago